Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Melatonin synergizes BRAF‐targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling
PaperCitations, authors & open-access status
Melatonin synergizes BRAF‐targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 19 citations, 2020 year and gold oa status.
19
Citations
2020
Year
gold
OA Status